BioSpace News Archive

Drug Development

New Detailed Phase 3 Data Show Amgen’s Novel Cholesterol Drug Evolocumab Significantly Reduced LDL Cholesterol

June 2, 2014
·
16 min read
Drug Development

Eisai Inc.'s New Thyroid Cancer Drug Lenvatinib Shows Promise In Phase 3 Study

June 2, 2014
·
6 min read
Drug Development

Pivotal Data For Novartis AG’s LDE225 Promising In Phase 2 Basal Cell Carcinoma Trial

June 2, 2014
·
11 min read
Deals

Albany Molecular Research, Inc. (AMRI) Ponies Up $110 Million For OSO BioPharmaceuticals Manufacturing, LLC

June 2, 2014
·
10 min read
FDA

Omeros Corporation Receives FDA Approval Of Omidria For Use In Cataract And Other Intraocular Lens Replacement Procedures

June 2, 2014
·
8 min read
Drug Development

Janssen Pharmaceutical Inc. ‘s Ibrutinib Triples Progression-Free Survival, Doubles Overall Survival In Phase 3 Leukemia Study

June 2, 2014
·
16 min read
CPhI Istanbul: Pharma’s Gateway To High-Growth Markets Of Eurasia, Central Asia And MENA Regions

June 2, 2014
·
5 min read
Drug Development

OncoSec Medical Inc. Presents Positive Phase 2 Interim Data Evaluating ImmunoPulse In Melanoma

June 2, 2014
·
1 min read
Deals

PharmaCell BV To Finalize Purchase Of Cell Therapy Production Facility

June 2, 2014
·
2 min read
Drug Development

CEL-SCI Receives Approval To Expand Its Immunotherapy Phase 3 Head And Neck Cancer Trial Into The United Kingdom

June 2, 2014
·
1 min read